Introduction
The adult (Type 1) form of Gaucher disease is probably the most prevalent glycolipid storage disease, usually occurring in Jewish patients and often presenting in the second or third decade of life. ' The disease results from a deficiency of pglucocerebrosidase (P-glucosidase) activity and is characterized by the presence of large and characteristic lipid-laden macrophages or Gaucher cells, particularly in the spleen but also in bone marrow, liver and lymph nodes. A few cases of proven Gaucher disease associated with leukaemia have been reported.2-4 We describe a patient with adult Gaucher disease who progressed to develop acute non-lymphoid leukaemia.
Case report
A 67 year old man of Scottish birth and ancestry presented in September 1982 with a history of increasing fatigue over a 12 month period. He also complained of central chest pain on exertion for which his general practitioner had been prescribing nifedipine. There was a past history of heavy alcohol intake, but this had moderated in recent years. He had two brothers and two children, all of whom were alive and well.
Examination showed a man with sallow and waxy skin who did not appear ill. The only positive finding was a 4 cm enlarged spleen. Investigation showed a haemoglobin concentration of 9.2 g/dl, total white cell count of 3.3 x 109/l and platelet count of 18 x 109/l. Routine biochemistry, including liver function tests and acid phosphatase, was normal. Chest and bone radiographs were unremarkable and abdominal computed tomographic (CT) scan confirmed his splenomegaly but revealed no other pathology. Both red cell and indium labelled platelet survival were shortened with an increase in splenic uptake. These initial investigations were consistent with moderate hypersplenism. Further investigation revealed the bone marrow aspirate to be heavily infiltrated with mature histiocytes (periodic acid-Schiff and acid phosphatase positive), which were also heavily laden with iron. A minor degree of erythrophagocytosis was seen. On electron microscopy the histiocytes had the characteristic appearance of Gaucher cells. Leucocyte Pglucosidase activity at 0.54 nmol/h per mg protein (controls 13.9 ± 4.7 units, n = 16) was reduced to 4% normal whereas activity in leucocytes from the daughter was partially reduced (47%) consistent with heterozygosity, although normal (121%) P-glucosidase activity was found in the son's leucocytes. Diagnosis was confirmed on cultured fibroblasts from the patient, which had 12.6 nmol/h per mg protein Pglucosidase activity, control value being 432 ± 78 units (n = 4).
After establishing the diagnosis the only therapy given was transfusional support. Because of his ischaemic heart disease he was initially considered to be unfit for splenectomy.
On a subsequent admission in November 1983 his full blood count showed a haemoglobin of 6 
Discussion
An association between Gaucher disease and acute leukaemia was first suggested by Gelfand & Gribroff,2 who reported the development of acute leukaemia in two patients with Gaucher disease. One, a 60 year old man, developed acute myeloid leukaemia and the other, a 55 year old man, progressed to acute lymphoblastic leukaemia. A further two patients with adult Gaucher disease developing acute myeloid leukaemia, have been reported;3 both patients died during induction therapy. Rosner5 described a 6 year old child with acute lymphoblastic leukaemia, Gaucher cells in his marrow and a family history of Gaucher disease, although enzymatic diagnosis was not established. In 1985, two cases of acute lymphoblastic leukaemia (ALL), one T-ALL and the other cALL, were described developing in children with Gaucher disease. 4 The presence of Gaucher-like cells in the bone marrow has been well documented in patients with leukaemia, particularly chronic myeloid leukaemia.67
However, in these cases P-glucosidase activity has been normal or increased and the presence of these cells may reflect an excess of phagocytic activity secondary to increased white cell turnover. In our patient however, P-glucosidase activity in both leucocytes and fibroblasts as well as spleen and brain,8 was reduced, consistent with the diagnosis of Gaucher disease. He also had one child, apparently heterozygous for this condition.
The other interesting feature concerning this patient was his late age of presentation. A few older patients have been reported,9-" but all these patients were Jewish and in some the diagnosis was incidental or followed family studies. Our patient was Scottish presenting at 67 years of age and his development of acute myeloid/monocytic leukaemia again raises the question of an association between Type 1 Gaucher disease and malignancy. 
